VCAM1 antibody (full length)
Quick Overview for VCAM1 antibody (full length) (ABIN7879307)
Target
See all VCAM1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- full length
-
Purpose
- CD106 Antibody / VCAM1 (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the CD106 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the CD106 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the CD106 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- VCAM1 (Vascular Cell Adhesion Molecule 1 (VCAM1))
-
Alternative Name
- CD106
-
Background
- Recognizes a protein of 110 kDa, identified as CD106 (also known as vascular cell adhesion molecule-1 (VCAM-1) and INCAM-100). CD106 is a member of the Ig superfamily of adhesion molecules and is expressed at high levels on cytokine stimulated vascular endothelial cells, and at minimal levels on un-stimulated endothelial cells. It is also present on follicular and inter-follicular dendritic cells of lymph nodes, myoblasts, and some macrophages. CD106 serves as a ligand for leukocyte integrin (VLA-4 or CD49d/CD29) and mediates cell adhesion of leukocytes to activated endothelium. It plays a role in various immunological and inflammatory responses. This MAb inhibits the binding of leukocytes to VCAM-1 on stimulated endothelial cells.
-
UniProt
- P19320
-
Pathways
- Carbohydrate Homeostasis
Target
-